Just another WordPress site

Secretaría Técnica AMIFE
c/ Cronos, 20, Portal 4, 1º, 6ª Madrid, 28037


Date: Wednesday, May 29, 2024

Time Schedule:
05:00 – 07:00 AM EST
09:00 – 11:00 AM GMT
11:00 – 01:00 PM CEST
06:00 – 08:00 PM JST

CAR T – Cell Theraphy and Ethical Aspects (patients’ involvement)

CAR T-cell therapy has demonstrated high response rates, particularly in certain types of blood cancers like acute lymphoblastic leukemia (ALL) and certain types of lymphoma. It has provided durable remissions in some patients who have not responded to other treatments.
CAR T-cell therapy specifically targets cancer cells by recognising specific proteins (antigens) on their surface.
Besides the side effects like cytokine release syndrome (CRS) and neurotoxicity the most discussed topic is the access to treatment for patients. This in the light of the rarity of specialised centres and the expensive costs. This high cost can pose financial challenges for patients and healthcare systems, potentially limiting access to those who could benefit from the treatment.
Therefore, patients’ involvement plays an important role in the ethical considerations in the CAR T-Cell therapy.

Register in advance for this webinar HERE. After registering, you will receive a confirmation email containing information about joining the webinar.

Speaker: DR. ANTONIO PÉREZ MARTÍNEZ, University Hospital La Paz, Madrid – Spain

Panelists: DR. YASUHIKO MIYATA, Director of Clinical Development and Medical Affairs, Miltenyi Biomedicine, Japan and DR. INGRID KLINGMANN, EFGCP, Brussels – Belgium

Moderator: ANNA JURCZYNSKA, IFAPP BOO Secretary and Delegate, Madrid – Spain

Register in advance HERE.